Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome.
about
Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesisRestless Legs Syndrome: Current Concepts about Disease PathophysiologyRestless Legs Syndrome and Leg Motor Restlessness in Parkinson's DiseaseTreatment of restless legs syndromeImaging brain functional and metabolic changes in restless legs syndrome.Brain imaging and networks in restless legs syndrome.Neuroimaging insights into the pathophysiology of sleep disordersRestless legs syndrome: pathophysiology and modern management.Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation.The dopamine transporter is decreased in the striatum of subjects with restless legs syndromePrevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation.Apomorphine in idiopathic restless legs syndrome: an exploratory study.Genetic markers of Restless Legs Syndrome in Parkinson diseaseRestless legs syndrome: an overview of the current understanding and management.In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease.Ropinirole in the treatment of restless legs syndrome.DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome.Periodic limb movements and other movement disorders in sleep: neuropsychiatric dimensions.Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.Increased synaptic dopamine in the putamen in restless legs syndrome.Restless legs syndrome and Parkinson's disease: is there an etiologic link?Pathophysiological concepts of restless legs syndrome.Animal studies in restless legs syndrome.Circadian and sleep disorders in Parkinson's disease.Elevated estradiol plasma levels in women with restless legs during pregnancyRestless legs syndrome: pathophysiology, diagnosis and treatment.Ropinirole for the treatment of restless legs syndrome.Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.Circadian Change in Blink Reflex Recovery in Restless Legs SyndromeEffects of rotigotine on Parkinson's disease-related sleep disturbances.Implications of nocturnal symptoms towards the early diagnosis of Parkinson's disease.Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings.Motor hyperactivity of the iron-deficient rat - an animal model of restless legs syndrome.Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology.Basal cardiac autonomic tone is normal in patients with periodic leg movements during sleep.Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients.Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson's disease.Evaluation of contributing factors to restless legs syndrome in migraine patients.
P2860
Q24657853-9FB64AE8-2586-4C0D-B127-88F1AA42463FQ26740533-254C4520-53C6-43F9-9399-41AB4EBE064CQ26778625-19A35D91-D61F-462F-BFED-3185EAAB19D4Q27024585-CC97CC19-7D8B-49BE-B4A7-085BCDCC6C3FQ30656967-172EBE61-9BF3-4E97-B36C-ADCDACAA3A42Q31142064-BF27C539-53D1-4119-B695-40D616BD0236Q31158979-0B2454E5-4361-452B-866F-F553CE2D48A8Q34335020-C8D7CD54-BCB6-4733-A20D-189D4F4EAA59Q34566322-80528809-722C-4052-AFB8-9F3DEF709DA0Q34585898-758ABE50-E42C-4F95-8B3B-A766EFB4AC3AQ35348138-36984E5F-CD63-4658-9125-F8AE1BC4CFB6Q35486302-ED3B5FA6-0EDC-48AB-BBE3-83082F31805EQ35638885-9EEC4296-E63F-4106-8983-AAC8CA68CBD5Q35744460-11C9E147-F8F4-462D-A1A8-004630925942Q35866876-30E49232-7FBB-4973-B43C-BA5358422881Q35957378-FA900AA0-842E-49A2-A2FB-1A8AEA5A83B0Q36106752-0BE498E9-01B8-4832-BA53-5377B665828EQ36109833-0F508738-038E-4F19-8490-9950E78E323DQ36272553-D1C60AC1-E065-4FEE-88B7-D9A8904B136AQ36444445-956CFE34-6749-4F4F-A141-ED5AE7E33D52Q36473245-DE61E32F-2E5F-4286-AA34-219332213D76Q36666563-5D234239-863C-4F85-B39A-97B5EC4DF6BCQ36827997-48C9F39C-5AB4-4C9A-A3B8-89C881297E12Q36862202-7710E790-0EA0-4ADE-B04E-5D591C7B537CQ36882599-00A29C1C-162C-4642-973F-7216CE3A6882Q37083139-1D536B07-E26C-4161-B1C4-76085FB8C188Q37165507-5B4C727E-A701-405E-9572-A7857A901132Q37166108-B13AD8E5-00F3-41B1-B17C-09841EC93B5BQ37319535-4F36E2DA-5C6F-428B-8153-B2D8ADF8A6E8Q37735547-026A47C8-BDE5-4297-AA55-896F5C3608B2Q38153751-B3E62F67-12E3-436B-A298-549C8F111DD2Q38185511-34E780FC-3BD1-441F-8B91-896D3745CE4BQ44773136-1FE443FA-E6E0-4010-98DA-0CD4C3E90C33Q45076649-B8CF3407-54AF-4A07-BC97-7116875215A2Q46105546-67B4AB7F-C2B0-46FB-8C2C-B974CED519A8Q47341364-64213E43-1926-4620-9891-8FF2979243BDQ48143325-EB4B38D8-3963-46C2-8979-1DC33E4CA272Q48176784-84D66960-3B0D-4C39-8C0D-B5B51B8890FEQ48252870-DEC76F48-C0CD-48AC-AF0D-C3001BC3DFE1Q48304756-606BC0F2-7FF7-4A42-9D11-194FB29ADFC3
P2860
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Normal IPT and IBZM SPECT in d ...... pathic restless legs syndrome.
@en
Normal IPT and IBZM SPECT in d ...... pathic restless legs syndrome.
@nl
type
label
Normal IPT and IBZM SPECT in d ...... pathic restless legs syndrome.
@en
Normal IPT and IBZM SPECT in d ...... pathic restless legs syndrome.
@nl
prefLabel
Normal IPT and IBZM SPECT in d ...... pathic restless legs syndrome.
@en
Normal IPT and IBZM SPECT in d ...... pathic restless legs syndrome.
@nl
P2093
P356
P1433
P1476
Normal IPT and IBZM SPECT in d ...... pathic restless legs syndrome.
@en
P2093
Eisensehr I
Gildehaus FJ
Noachtar S
Trenkwalder C
von Lindeiner H
P304
P356
10.1212/WNL.57.7.1307
P407
P577
2001-10-01T00:00:00Z